首页> 美国卫生研究院文献>ESC Heart Failure >Impella RP as a bridge to cardiac transplant for refractory late right ventricular failure in setting of left ventricular assist device
【2h】

Impella RP as a bridge to cardiac transplant for refractory late right ventricular failure in setting of left ventricular assist device

机译:Impella RP可作为难治性右室晚期晚期左室辅助装置中心脏移植的桥梁

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Right ventricular (RV) failure remains a major complication after surgical implantation of a left ventricular assist device (LVAD). While the use of a percutaneous RV assist device has been described as a short‐term bridge to recovery in end‐stage heart failure patients with early post‐operative RV failure after index LVAD implant, management of refractory late RV failure remains challenging in these patients. We report the first successful case of extended Impella RP use as a safe and effective bridge to orthotopic heart transplant in an LVAD patient with refractory, haemodynamically significant late RV failure. The Impella RP provided support for 37 days. Haemodynamically intolerant arrhythmia precluded use of inotropic support. No adverse complications related to percutaneous Impella RP support were seen. We also review potential considerations for mechanical circulatory support strategies in this setting: central RV assist device cannulation requires sternotomy incision that can impact subsequent cardiac surgeries, while percutaneous Protek Duo insertion requires adequate vessel size and patency. With an LVAD , veno‐arterial extracorporeal membrane oxygenation was not considered for isolated RV support in this case. The patient is currently over 6 months post‐orthotopic heart transplant.
机译:手术植入左心室辅助装置(LVAD)后,右心室(RV)衰竭仍是主要并发症。虽然经皮RV辅助设备的使用已被描述为在LVAD指数植入后术后早期RV失败的晚期心力衰竭患者中恢复康复的短期桥梁,但这些患者难治性晚期RV失败的管理仍面临挑战。我们报道了在顽固性,血液动力学上显着的晚期RV衰竭的LVAD患者中,首次成功扩大Impella RP的使用作为安全,有效地通向原位心脏移植的桥梁的成功案例。 Impella RP提供了37天的支持。血液动力学不耐受的心律不齐,禁止使用正性肌力支持剂。没有发现与经皮Impella RP支持相关的不良并发症。在这种情况下,我们还回顾了机械循环支持策略的潜在考虑因素:中央RV辅助设备插管需要切开胸骨切口,这可能会影响随后的心脏手术,而经皮Protek Duo插入则需要足够的血管大小和通畅性。对于LVAD,在这种情况下,不考虑静脉-动脉体外膜氧合作为单独的RV支持。该患者目前在原位心脏移植后6个月以上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号